Immediate Impact
33 standout
Citing Papers
Role of SLC7A11/xCT in Ovarian Cancer
2024 Standout
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Works of Mahnaz Rezaei being referenced
The MDM2 promoter T309G polymorphism was associated with preeclampsia susceptibility
2017
The ID genotype of MDM2 40 bp insertion/deletion polymorphism was associated with lower risk of SLE
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Mahnaz Rezaei | 127 | 118 | 88 | 38 | 312 | |
| T Kolben | 77 | 97 | 67 | 36 | 354 | |
| Batool Teimoori | 182 | 77 | 91 | 34 | 310 | |
| Weiqing Song | 73 | 81 | 36 | 25 | 303 | |
| Xiulong Niu | 99 | 108 | 73 | 26 | 368 | |
| Dabao Wu | 76 | 114 | 49 | 31 | 317 | |
| Sandra Zekić Tomaš | 164 | 69 | 37 | 34 | 324 | |
| Naoyuki Iwahashi | 76 | 108 | 98 | 28 | 310 | |
| Filiz Özen | 88 | 93 | 19 | 30 | 330 | |
| Kaname Uno | 130 | 90 | 45 | 42 | 370 | |
| Jozef Višňovský | 94 | 150 | 65 | 45 | 369 |
All Works
Login with ORCID to disown or claim papers
Loading papers...